genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Levodopa
Featured
Parkinson’s Symptom, Resting Tremor, Relates to Dopamine in Unexpected Way
Drug Discovery
Alzheimer’s Disease Symptoms Lessened and Improved in Mice by Dopamine Treatment
News
FDA Extends PDUFA Date for Acorda’s Inbrija, 3 Days after Company Loses Ampyra Appeal
Industry News
FDA Refuses to File Acorda NDA for Inbrija
Drug Discovery
Adamas’ Gocovri Wins FDA Nod as First PD Treatment for Levodopa-Induced Dyskinesia
Drug Discovery
Mitsubishi Tanabe to Buy Parkinson’s Disease Drugs Firm NeuroDerm for $1.1B
News
Lasker 2014 Awards Honor Five Scientists Excelling in Basic and Applied Clinical Research
News
MJFF Supports Trial Evaluating Treatment for Levodopa-Induced Dyskinesia
Drug Discovery
Envoy Awarded MJFF Grant to Develop Oral Drug for Parkinson Disease
News
Adolor Awarded $0.3M by MJFF to Develop PD Drugs for Levodopa-Induced Dyskinesia
1
2
Page 1 of 2
Scroll Up
Scroll Up
